Chambal Fertilizers & Chemicals Limited (CHAMBLFERT)
🎯 Key Takeaways
- Chambal Fertilizers & Chemicals Limited is transitioning from a traditional urea-centric fertilizer producer to a more diversified agrochemical and specialty nutrients player, with recent financial performance reflecting successful execution of this strategic shift. The company has demonstrated consistent revenue and margin expansion across consolidated and standalone operations, particularly in non-urea segments like Specialty Nutrients, Seeds, and Biologicals, signaling improved operational resilience and market positioning.
- Revenue grew 13.2% QoQ to ₹4,918 in Q3FY25.
- ⚠️ 1) Overreliance on urea for revenue share (~10% market share) exposes the company to input cost volatility and regulatory price controls. 2) Rapid gro
📖 The Story
Chambal Fertilizers & Chemicals Limited is transitioning from a traditional urea-centric fertilizer producer to a more diversified agrochemical and specialty nutrients player, with recent financial performance reflecting successful execution of this strategic shift. The company has demonstrated consistent revenue and margin expansion across consolidated and standalone operations, particularly in non-urea segments like Specialty Nutrients, Seeds, and Biologicals, signaling improved operational resilience and market positioning.
📰 What's Happening
In FY26, the company reported consolidated revenue of ₹207,937 crores, up 25% YoY, driven by strong performance in CPC, Speciality Nutrients, Seeds (+27% YoY), and Biologicals (+57% revenue). Consolidated net profit rose 18% to ₹19,533 crores, with EBITDA surging 56% to ₹2,551 crores and margins expanding to 9.16%. The standalone Q4 revenue reached ₹27,850 crores (+14% YoY) and net profit increased 30% to ₹1,454 crores, supported by progress on the Technical Ammonium Nitrate plant and improved market share in urea (~10% with 3.4 MMTPA capacity).
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q4FY23 | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,599 | 5,589 | 5,386 | 4,349 | 2,643 | 4,933 | 4,346 | 4,918 |
| Operating Profit | 153 | 642 | 697 | 724 | 229 | 803 | 834 | 843 |
| OPM % | 3.1% | 11.3% | 11.4% | 14.4% | 6.3% | 15.2% | 18.2% | 15.8% |
| Net Profit | 94 | 339 | 381 | 459 | 97 | 448 | 536 | 534 |
| EPS | ₹2.26 | ₹8.14 | ₹9.15 | ₹11.04 | ₹2.51 | ₹11.19 | ₹13.39 | ₹13.34 |
The company's financial trajectory shows a clear inflection point, with standalone revenue growing from ₹5,589 crores in Q1FY24 to ₹27,850 crores in Q4FY25, and net profit rising from ₹339 crores to ₹1,454 crores over the same period. Operating margins have stabilized around 15-18% in recent quarters after a low of 3.1% in Q4FY23, indicating effective cost management and scale benefits. The sharp EBITDA growth to ₹2,551 crores in FY26 underscores improving operational efficiency and the positive impact of segmental diversification beyond urea.
🔮 Management Outlook & What's Next
Management has emphasized the strategic importance of reducing urea dependency and accelerating growth in high-margin segments like Specialty Nutrients, Biologicals, and Seeds. The company highlighted the progress on the Technical Ammonium Nitrate plant as a key enabler for value-added production. While no formal forward guidance was provided in the latest filings, the consistent upward trend in revenue and profitability across segments reflects management's confidence in sustaining the current momentum.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Fertilizers & Agrochemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Fertilizers and Chemicals Travancore Limited | 57,117 | -630.5 | — | — | — |
| Coromandel International Limited | 55,044 | 33.3 | — | — | — |
| UPL Limited | 53,373 | -157.3 | — | — | — |
| PI Industries Limited | 47,259 | 27.8 | — | — | — |
| Sumitomo Chemical India Limited | 22,898 | 44.4 | — | — | — |
| Bayer Cropscience Limited | 21,796 | — | — | — | — |
| Chambal Fertilizers & Chemicals Limited | 18,025 | 11.1 | — | — | — |
| Paradeep Phosphates Limited | 12,506 | 30.3 | — | — | — |
| Sharda Cropchem Limited | 8,742 | 35.8 | — | — | — |
| Rashtriya Chemicals and Fertilizers Limited | 6,876 | 25.9 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Overreliance on urea for revenue share (~10% market share) exposes the company to input cost volatility and regulatory price controls. 2) Rapid growth in non-urea segments, while promising, may face scaling challenges and increased competition from specialized players. 3) The Technical Ammonium Nitrate plant, though progressing, carries execution and regulatory risks that could delay anticipated margin benefits. 4) Raw material price fluctuations, particularly in natural gas and ammonia, remain a persistent headwind with limited pass-through capability in competitive markets.
📋 Recent Filings
-
🔴 Announcement 15 June 2026No summary available
-
🔴 Announcement 12 June 2026No summary available
-
🔴 Announcement 10 June 2026No summary available
-
🔴 Insider Trading 9 June 2026Zuari Industries disclosed via SEBI filing that it and persons acting in concert made no additional encumbrance on Chambal Fertilizers shares during F...
-
🔴 Announcement 5 June 2026No summary available
-
🔴 Announcement 3 June 2026No summary available
-
Announcement 1 June 2026Chambal Fertilizers announced that production of Weak Nitric Acid (WNA) has started at its Gadepan plant, with Ammonium Nitrate Solution and High Dens...
-
🔴 Announcement 19 May 2026No summary available
-
🟡 Board Meeting 14 May 2026Chambal Fertilizers & Chemicals Limited announced the outcome of its May 14, 2026 board meeting, approving audited standalone and consolidated financi...
-
🔴 Financial Results 14 May 2026Chambal Fertilizers reported FY26 consolidated revenue of **₹207,937 crores**, up 25% YoY, with consolidated net profit rising 18% to **₹19,533 crores...
🧠 Analyst's Read
Chambal Fertilizers is undergoing a structural transformation with measurable early success, as evidenced by robust revenue diversification and margin expansion. Investors should monitor the pace of growth in Specialty Nutrients and Biologicals, the ramp-up of the Technical Ammonium Nitrate plant, and management's ability to sustain profitability amid input cost pressures. The next earnings cycle will be critical in validating the sustainability of current momentum.
Based on filing content and financial data. Not a recommendation.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-16.